Approval · Notice of Compliance 37961 · 2026
TRYNGOLZA: Notice of Compliance 37961
Issued July 20, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37961
- Date
- July 20, 2026
- Company
- Celystra Pharma Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRYNGOLZA | 02563886 | Marketed |
Medicinal ingredients
- OLEZARSEN SODIUM 80 MG per 0.8ML